NCT01067807 - Proellex Pharmacokinetics Bridging Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions

Healthy

Interventions

DRUG

25 mg Proellex

25 mg - given as one 25 mg capsule (252 mg of Gelucire and 88 mg of PEG400, original formulation) \[Original\], single dose

DRUG

25 mg Proellex

25 mg - given as one 25 mg capsule (coated with microcrystalline cellulose, new formulation) (coated), single dose

DRUG

25 mg Proellex

25 mg - given as one 25 mg capsule (blended with microcrystalline cellulose, new formulation) \[Blended\], single dose

DRUG

50 mg Proellex

50 mg - given as two 25 mg capsules (blended with microcrystalline cellulose, new formulation) \[Blended\], single dose

Trial Locations (1)

Healthcare Discoveries, Inc, San Antonio

All Listed Sponsors

lead

Repros Therapeutics Inc.

INDUSTRY